The pathophysiological basis of dystonias

被引:332
作者
Breakefield, Xandra O. [1 ,2 ]
Blood, Anne J. [2 ,7 ]
Li, Yuqing [3 ,4 ]
Hallett, Mark [5 ]
Hanson, Phyllis I. [6 ]
Standaert, David G. [3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol & Radiol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA
[5] NINDS, Med Neurol Branch, Bethesda, MD 20892 USA
[6] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
[7] Massachusetts Gen Hosp, Dept Psychiat & Neurol & Athinoula, A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA
关键词
D O I
10.1038/nrn2337
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dystonias comprise a group of movement disorders that are characterized by involuntary movements and postures. Insight into the nature of neuronal dysfunction has been provided by the identification of genes responsible for primary dystonias, the characterization of animal models and functional evaluations and in vivo brain imaging of patients with dystonia. The data suggest that alterations in neuronal development and communication within the brain create a susceptible substratum for dystonia. Although there is no overt neurodegeneration in most forms of dystonia, there are functional and microstructural brain alterations. Dystonia offers a window into the mechanisms whereby subtle changes in neuronal function, particularly in sensorimotor circuits that are associated with motor learning and memory, can corrupt normal coordination and lead to a disabling motor disorder.
引用
收藏
页码:222 / 234
页数:13
相关论文
共 131 条
[1]   Mutations in the Na+/K+-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism [J].
Aguiar, PD ;
Sweadner, KJ ;
Penniston, JT ;
Zaremba, J ;
Liu, L ;
Caton, M ;
Linazasoro, G ;
Borg, M ;
Tijssen, MAJ ;
Bressman, SB ;
Dobyns, WB ;
Brashear, A ;
Ozelius, LJ .
NEURON, 2004, 43 (02) :169-175
[2]  
Alterman RL, 2007, ACTA NEUROCHIR SUPPL, V97, P191
[3]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[4]   Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation [J].
Asanuma, K ;
Ma, Y ;
Okulski, J ;
Dhawan, V ;
Chaly, T ;
Carbon, M ;
Bressman, SB ;
Eidelberg, D .
NEUROLOGY, 2005, 64 (02) :347-349
[5]   Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene [J].
Asmus, F ;
Salih, F ;
Hjermind, LE ;
Ostergaard, K ;
Munz, M ;
Kühn, AA ;
Dupont, E ;
Kupsch, A ;
Gasser, T .
ANNALS OF NEUROLOGY, 2005, 58 (05) :792-797
[6]  
Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.0.CO
[7]  
2-Z
[8]   Dopamine release is impaired in a mouse model of DYT1 dystonia [J].
Balcioglu, Aygul ;
Kim, Mee-Ohk ;
Sharma, Nutan ;
Cha, Jang-Ho ;
Breakefield, Xandra O. ;
Standaert, David G. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (03) :783-788
[9]   Abnormal somatosensory homunculus in dystonia of the hand [J].
Bara-Jimenez, W ;
Catalan, MJ ;
Hallett, M ;
Gerloff, C .
ANNALS OF NEUROLOGY, 1998, 44 (05) :828-831
[10]   The pathophysiology of primary dystonia [J].
Berardelli, A ;
Rothwell, JC ;
Hallett, M ;
Thompson, PD ;
Manfredi, M ;
Marsden, CD .
BRAIN, 1998, 121 :1195-1212